C12Y 304/22034
Legumain , i.e. asparaginyl endopeptidase
Official title: Legumain (3.4.22.34), i.e. asparaginyl endopeptidase
C12Y304/22034 (Legumain , i.e. asparaginyl endopeptidase) appears on 1 US grants and 12 published applications in this corpus.
Search patents in C12Y- Granted patents
- 1
- Published applications
- 12
- Assignees
- 12
- Inventors
- 58
- Latest grant
- 29 Aug 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 2 |
| 2022 | 0 | 1 |
| 2023 | 1 | 1 |
| 2024 | 0 | 4 |
| 2025 | 0 | 1 |
By publication year.
Recent patents
- Ribosomal Biosynthesis Of Moroidin Peptides In Plants16 Jan 2025US 2025/0019715 A1Whitehead Institute for Biomedical Research
- Mitigation of therapeutic protein fragmentation during cell culture harvest processes8 Aug 2024US 2024/0262908 A1Amgen Inc.
- Methods for ligation of (poly)peptides and oligonucleotides13 Jun 2024US 2024/0191276 A1
- Methods for (poly) peptide tandem ligation and cyclization11 Apr 2024US 2024/0117402 A1Nanyang Technological University
- Surface Modified Red Blood Cells And Methods Of Generating The Same4 Apr 2024US 2024/0110153 A1City University of Hong Kong
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.